| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cb8f3eba86915d967beefc175437273a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D417-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D419-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D493-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-06 |
| filingDate |
2008-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2011-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4712e04752b73bfb664f9ffa6eb2ca30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e1ff76c28fff7737856ea9ec301ba9ca
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7511e51e931d45fb7677cfdb55c70669
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_860173735b5a556e3eda7f729b56557c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cdcb651c0654471a84b2bf027b973292
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ddeea45e97fe7565431f09c61b96ca03
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9e8bcf1e531b03bb3c3c4df0c348b8ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_98d5aee8cc7dd69912b805ca0f3205c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86da1ee065368288dcecbf3b2d3fd39a |
| publicationDate |
2011-01-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-7875638-B2 |
| titleOfInvention |
Synthesis of epothilones, intermediates thereto, analogues and uses thereof |
| abstract |
The present invention provides compounds of formula (I): n n n n n n n n n n n n as described generally and in classes and subclasses herein. The present invention additionally provides pharmaceutical compositions comprising compounds of formula (I) and provides methods of treating cancer comprising administering a compound of formula (I). |
| priorityDate |
2002-08-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |